title: Companies compete over mutation-specific melanoma drugs.
authors.forename: Cassandra
authors.initials: C
authors.lastname: Willyard
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004345:Drug Industry; D004465:Economic Competition; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000235:genetics; D009154:Mutation; D048493:Proto-Oncogene Proteins B-raf / Q000187:drug effects / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf